Newly Developed Psoriasis in a Patient with Telangiectasia Macularis Eruptiva Perstans and Systemic Mastocytosis Treated with Interferon.

Authors :: Péčová T
Burjanivová T
Malicherová B
Péč MJ
Rohoň I
Madleňák M
Adamicová K
Péč J
Source :: Case reports in dermatology [Case Rep Dermatol] 2021 Dec 07; Vol. 13 (3), pp. 558-562. Date of Electronic Publication: 2021 Dec 07 (Print Publication: 2021).
Publication Year :: 2021
Abstract: The authors present a rare case of a patient with telangiectasia macular eruptiva perstans, with confirmed D816V mutation which later progressed to systemic mastocytosis confirmed by trepanobiopsy. First-line treatment - phototherapy - had to be stopped, and systemic treatment with interferon alpha-2a was initiated. The treatment was successful with regression of skin lesions as well as mast cell infiltrates in the bone marrow. However, the treatment was complicated by the onset of psoriasis lesions.<br />Competing Interests: The authors have no conflicts of interest to declare.<br /> (Copyright © 2021 by S. Karger AG, Basel.)

Full Text Access

Tools